James C Hamilton
Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. (ARWR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 24SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 10,000226,958 held (−4%) | $75.00 | $750K | -16.3% |
| Mar 9SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 10,000236,958 held (−4%) | $64.19 | $642K | -2.2% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 4,625207,497 held (−2%) | $61.24 | $283K | +2.5% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 6,090201,407 held (−3%) | $62.28 | $379K | +0.8% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 14,792186,615 held (−7%) | $63.01 | $932K | -0.4% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 12,711173,904 held (−7%) | $63.95 | $813K | -1.9% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 1,200172,704 held (−1%) | $64.49 | $77K | -2.7% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 437172,267 held (−0%) | $65.97 | $29K | -4.9% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 309171,958 held (−0%) | $68.00 | $21K | -7.7% |
| Oct 3SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 20,000212,122 held (−9%) | $35.00 | $700K | +79.3% |
- Sell
Chief Medical Officer James C Hamilton sold $750K of ARWR at $75.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer James C Hamilton sold $642K of ARWR at $64.19 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer James C Hamilton sold $283K of ARWR at $61.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer James C Hamilton sold $379K of ARWR at $62.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer James C Hamilton sold $932K of ARWR at $63.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer James C Hamilton sold $813K of ARWR at $63.95 — pre-scheduled 10b5-1 plan sale.